Daniel Yerace
2023
In 2023, Daniel Yerace earned a total compensation of $360K as Vice President of Operations at Coeptis Therapeutics Holdings, which was about the same as previous year.
Compensation breakdown
| Salary | $360,000 |
|---|---|
| Total | $360,000 |
Yerace received $360K in salary, accounting for 100% of the total pay in 2023.
Rankings
In 2023, Daniel Yerace's compensation ranked 2,362nd out of 2,978 executives tracked by ExecPay. In other words, Yerace earned more than 20.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,362 out of 2,978 | 21st |
Division Manufacturing | 1,326 out of 1,637 | 19th |
Major group Chemicals And Allied Products | 777 out of 906 | 14th |
Industry group Drugs | 758 out of 869 | 13th |
Industry Biological Products, Except Diagnostic Substances | 192 out of 211 | 9th |
Source: SEC filing on November 14, 2024.
Yerace's colleagues
We found four more compensation records of executives who worked with Daniel Yerace at Coeptis Therapeutics Holdings in 2023.
2023
David Mehalick
Coeptis Therapeutics Holdings
Chief Executive Officer
2023
Colleen Delaney
Coeptis Therapeutics Holdings
Chief Financial Officer
2023
Brian Cogley
Coeptis Therapeutics Holdings
Chief Financial Officer
2023
Christine Sheehy
Coeptis Therapeutics Holdings